DEVICE THIRD-PARTY REVIEW LANGUAGE REMAINS STICKING POINT IN SENATE, HOUSE FDA REFORM BILLS; HOUSE SUBCOMMITTEE MARK-UP EXPECTED BY MID-JULY
This article was originally published in The Gray Sheet
Executive Summary
Reducing the number of Class III devices eligible for review by third-party groups could be a point of compromise in the Senate's FDA reform bill as Republican lawmakers strive to hammer out a bill that the Administration will support in the final weeks of the 1996 congressional session.